1. Market Research
  2. > Circassia Holdings Ltd. - Product Pipeline Review - 2013

Circassia Holdings Ltd. - Product Pipeline Review - 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 37 pages

Circassia Holdings Ltd. - Product Pipeline Review - 2013

Summary

Global Markets Direct’s pharmaceuticals report, “Circassia Holdings Ltd. - Product Pipeline Review - 2013” provides data on the Circassia Holdings Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Circassia Holdings Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Circassia Holdings Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Circassia Holdings Ltd. - Brief Circassia Holdings Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Circassia Holdings Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Circassia Holdings Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Circassia Holdings Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Circassia Holdings Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Circassia Holdings Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Circassia Holdings Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Circassia Holdings Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Circassia Holdings Ltd. and identify potential opportunities in those areas.

Table Of Contents

Circassia Holdings Ltd. - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Circassia Holdings Ltd. Snapshot 5
Circassia Holdings Ltd. Overview 5
Key Information 5
Key Facts 5
Circassia Holdings Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Circassia Holdings Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Circassia Holdings Ltd. - Pipeline Products Glance 10
Circassia Holdings Ltd. - Late Stage Pipeline 10
Phase III Products/Combination Treatment Modalities 10
Circassia Holdings Ltd. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Circassia Holdings Ltd. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Circassia Holdings Ltd. - Drug Profiles 15
CIR-001 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
Drug for Rheumatoid Arthritis 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
ToleroMune Alternaria Allergy T-Cell Vaccines 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
ToleroMune Birch Allergy T-Cell Vaccines 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
ToleroMune Cat Allergy T Cell Vaccine 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
ToleroMune Dog Allergy T Cell Vaccine 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
ToleroMune Grass Allergy T-cell Vaccine 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
ToleroMune House Dust Mite T Cell Vaccine 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
ToleroMune Japanese Cedar Allergy T Cell Vaccine 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
ToleroMune Ragweed Allergy T-cell Vaccine 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
Circassia Holdings Ltd. - Pipeline Analysis 25
Circassia Holdings Ltd. - Pipeline Products by Therapeutic Class 25
Circassia Holdings Ltd. - Pipeline Products By Target 27
Circassia Holdings Ltd. - Pipeline Products by Route of Administration 28
Circassia Holdings Ltd. - Pipeline Products By Mechanism of Action 29
Circassia Holdings Ltd. - Recent Pipeline Updates 30
Circassia Holdings Ltd. - Dormant Projects 34
Circassia Holdings Ltd. - Locations And Subsidiaries 35
Head Office 35
Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 36
Contact Us 37
Disclaimer 37

List of Tables

Circassia Holdings Ltd., Key Information 5
Circassia Holdings Ltd., Key Facts 5
Circassia Holdings Ltd. - Pipeline by Indication, 2013 7
Circassia Holdings Ltd. - Pipeline by Stage of Development, 2013 8
Circassia Holdings Ltd. - Monotherapy Products in Pipeline, 2013 9
Circassia Holdings Ltd. - Phase III, 2013 10
Circassia Holdings Ltd. - Phase II, 2013 11
Circassia Holdings Ltd. - Phase I, 2013 12
Circassia Holdings Ltd. - Preclinical, 2013 13
Circassia Holdings Ltd. - Discovery, 2013 14
Circassia Holdings Ltd. - Pipeline By Therapeutic Class, 2013 26
Circassia Holdings Ltd. - Pipeline By Target, 2013 27
Circassia Holdings Ltd. - Pipeline By Route of Administration, 2013 28
Circassia Holdings Ltd. - Pipeline Products By Mechanism of Action, 2013 29
Circassia Holdings Ltd. - Recent Pipeline Updates, 2013 30
Circassia Holdings Ltd. - Dormant Developmental Projects,2013 34

List of Figures

Circassia Holdings Ltd. - Pipeline by Indication, 2013 7
Circassia Holdings Ltd. - Pipeline by Stage of Development, 2013 8
Circassia Holdings Ltd. - Monotherapy Products in Pipeline, 2013 9
Circassia Holdings Ltd. - Pipeline By Therapeutic Class, 2013 25
Circassia Holdings Ltd. - Pipeline By Route of Administration, 2013 28

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.